GLP-1 medications at maximum doses produce 15 to 22.5% average weight loss
Am J Physiol 265:E380E391 Howlett RA, Parolin ML, Dyck DJ, Hultman E, Jones NL, Heigenhauser GJ, Spriet LL (1998) Regulation of skeletal muscle glycogen phosphorylase and PDH at varying exercise power outputs
These cards generally require commercial insurance that covers the drug and excludes individuals enrolled in government insurance programs such as Medicare and Medicaid
Ariceta G, Camacho JA, Fernandez-Obispo M, Fernandez-Polo A, Gamez J, Garcia-Villoria J, Lara Monteczuma E, Leyes P, Martin-Begue N, Oppenheimer F, Perello M, Morell GP, Torra R, Santandreu AV, Guell A, Grupo T-CiS.bcn (2015) Cystinosis in adult and adolescent patients: recommendations for the comprehensive care of cystinosis
Acknowledgments We would like to thank Editage (www.editage.cn) for English language editing
The FDA issued a warning letter regarding BPC-157 compounding in 2023, noting that bulk drug substances used in 503A compounding must meet specific quality standards